AzTrials
AzTrials

ConsciousnessCONSCIOUS-ICUNCT07048951

Episodes of (Dis)Connected Consciousness in ICU Survivors

An observational study of Consciousness and Near Death Experience, run by University of Liege at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This single-center observational study aims to describe the incidence of episodes of connected consciousness and disconnected consciousness (including near-death experience (NDE) and out-of-body experiences) in patients who survived a prolonged stay of at least 7 days in the intensive care unit (ICU) and who had at… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Consciousness, Near Death Experience, ICU
What is being tested?
The Near-Death Experience Content (NDE-C) scale, Threat perception measure and Interview about the participant's memories of the ICU
How many people
200 participants
Where
1 siteBelgium
Study dates
1 Apr 2025to Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All adult patients admitted in the ICU

Who may be able to join

  • Adult patients who survived a ≥7 days stay in the intensive care unit
  • Experienced a pharmacological or non-pharmacological episode of loss of consciousness
  • French speaking

Who cannot join

  • Refusal
  • Chronic disorder of consciousness
  • Confusion or delirium
  • Deafness
  • Blindness
  • Aphasia

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Charlotte Martial, PhD contact

+3243233612

cmartial@uliege.be

Belgium1 site, 1 recruiting
  • CHU of Liège

    Liège, Liège, 4000

    Recruiting

Other trials in Belgium

About this study

Official title: Episodes of (Dis)Connected Consciousness Among Patients Who Survived a Critical Illness

This single-center observational study aims to describe the incidence of episodes of connected consciousness and disconnected consciousness (including near-death experience (NDE) and out-of-body experiences) in patients who survived a prolonged stay of at least 7 days in the intensive care unit (ICU) and who had at least one episode of pharmacological or non-pharmacological coma. The investigators are also investigating the risk factors related to these episodes of consciousness. A follow-up at six months aims to explore the long-term psychological implications of these episodes.

Being tested
The Near-Death Experience Content (NDE-C) scale, Threat perception measure, Interview about the participant's memories of the ICU
Keywords
near-death experience, out-of-body experience
Medical subject headings
Death, Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Near-Death Experience Content (NDE-C) scaleDiagnostic test

    Questionnaire to detect occurence of NDE. A NDE is identified if score > or = 27/80

  • Threat perception measureOther

    7 items scale investigating the participant's psychological vulnerability during their stay at the ICU

  • Interview about the participant's memories of the ICUOther

    Participants will be asked to describe any dream, hallucination, or any other unusual experience they can recall from their stay at the ICU.

    Additionally, the participants will be asked to describe any memory they have of the environment of the ICU, such as the appearance of the room, medical staff, family visiting, noises, etc.

Study groups in NCT07048951
Study groupRoleWhat they receive
Survivors of prolonged ICU (≥7days) stay with episode(s) of pharmacological/non-pharmacological comaNot described
Receives: Diagnostic Test: The Near-Death Experience Content (NDE-C) scale; Other: Threat perception measure; Other: Interview about the participant's memories of the ICU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Detection of potential episodes of disconnected consciousness

    Near-death experience (using the Near-Death Experience Content scale, min-max: 0-80, with ≥27/80 indicating the presence of a NDE); dream

    Measured: Within the week following discharge from the ICU (max 7 days after)

  2. Detection of potential episodes of connected consciousness

    Explicit recall of environmental/external stimuli in the ICU

    Measured: Within the week following discharge from the ICU (max 7 days after)

Secondary outcomes (3)
  1. Risk factors

    (Neuro)physiological marker

    Measured: Within the week following discharge from the ICU (max 7 days after)

  2. Psychological vulnerability during the stay at the ICU

    Using the Threat Perception Measure, a scale that contains 7 items related to feelings and anxieties perceived by the patient, each scored from 1 to 4, ranging from 1 "Not at all", 2 "A little", 3 "Moderately", and 4 "Extremely", as well as a "don 't remember" category. Min-max: 7-28, with higher scores indicating a higher level of perceived threat

    Measured: Within the week following discharge from the ICU (max 7 days after)

  3. Psychological impact of the stay at the ICU

    Any patient who stayed at least 7 days at the ICU is invited to a 6 month follow-up during which they will be presented Hospital Anxiety and Depression Scale (HADS, min-max: 0-42, with higher scores indicating a worse outcome, i.e., more severe symptoms of anxiety or depression), to assess anxiety and depression as well as the Post-Traumatic Stress Assessment Questionnaire (IES-R, min-max: 0-88, with higher scores indicating a worse outcome, i.e., more severe post-traumatic stress symptoms).

    The investigators will be asking two additional questions to investigate a possible impact on the patient's beliefs.

    • Question 1: "Since your stay in intensive care, have your beliefs/opinions changed regarding death?".
    • Question 2: "Has your stay in intensive care modified your fear of health care institutions?

    Measured: At a 6 month follow-up after discharge from the ICU

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2025
  2. Study start1 Apr 2025
  3. Primary completionJan 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07048951
Sponsor's protocol ID
2024-254
Acronym
CONSCIOUS-ICU
Status last verified
Dec 2024
First submitted
7 Apr 2025
Last updated
3 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Consciousness and Near Death Experience, run by University of Liege at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Charlotte Martial, PhD (+3243233612, cmartial@uliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Detection of potential episodes of disconnected consciousness (time frame: Within the week following discharge from the ICU (max 7 days after)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2025; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in